148 related articles for article (PubMed ID: 36583449)
21. A migration case of Kii amyotrophic lateral sclerosis/parkinsonism dementia complex with the shortest stay in the endemic area and the longest incubation to develop the disease.
Tsunoda K; Yamashita T; Shimada H; Nomura E; Takahashi Y; Shang J; Sato K; Takemoto M; Hishikawa N; Ohta Y; Higuchi M; Suhara T; Kokubo Y; Kuzuhara S; Abe K
J Clin Neurosci; 2017 Dec; 46():64-67. PubMed ID: 28890043
[TBL] [Abstract][Full Text] [Related]
22. The ALS/PDC syndrome of Guam and the cycad hypothesis.
Bradley WG; Banack SA; Cox PA
Neurology; 2009 Feb; 72(5):473-4, 476; author reply 475-6. PubMed ID: 19195084
[No Abstract] [Full Text] [Related]
23. The ALS/PDC syndrome of Guam and the cycad hypothesis.
Spencer PS; Palmer V; Kisby G
Neurology; 2009 Feb; 72(5):474-6; author reply 475-6. PubMed ID: 19195086
[No Abstract] [Full Text] [Related]
24. The cycad genotoxin methylazoxymethanol, linked to Guam ALS/PDC, induces transcriptional mutagenesis.
Verheijen BM; Chung C; Thompson B; Kim H; Nakahara A; Anink JJ; Mills JD; ; Lee JH; Aronica E; Oyanagi K; Kakita A; Gout JF; Vermulst M
Acta Neuropathol Commun; 2024 Feb; 12(1):30. PubMed ID: 38383591
[No Abstract] [Full Text] [Related]
25. Identification of phosphorylation sites in PHF-TAU from patients with Guam amyotrophic lateral sclerosis/parkinsonism-dementia complex.
Mawal-Dewan M; Schmidt ML; Balin B; Perl DP; Lee VM; Trojanowski JQ
J Neuropathol Exp Neurol; 1996 Oct; 55(10):1051-9. PubMed ID: 8858002
[TBL] [Abstract][Full Text] [Related]
26. Incidence of amyotrophic lateral sclerosis and of the parkinsonism-dementia complex of Guam, 1950-1989.
Waring SC; Esteban-Santillan C; Reed DM; Craig UK; Labarthe DR; Petersen RC; Kurland LT
Neuroepidemiology; 2004; 23(4):192-200. PubMed ID: 15272222
[TBL] [Abstract][Full Text] [Related]
27. The ALS/PDC syndrome of Guam and the cycad hypothesis.
Cruz-Aguado R; Shaw CA
Neurology; 2009 Feb; 72(5):474, 476; author reply 475-6. PubMed ID: 19195085
[No Abstract] [Full Text] [Related]
28. The ALS/PDC syndrome of Guam and the cycad hypothesis.
Steele JC; McGeer PL
Neurology; 2008 May; 70(21):1984-90. PubMed ID: 18490618
[TBL] [Abstract][Full Text] [Related]
29. The ALS/PDC syndrome of Guam and the cycad hypothesis.
Borenstein AR; Mortimer JA; Schellenberg GD; Galasko D
Neurology; 2009 Feb; 72(5):473, 476; author reply 475-6. PubMed ID: 19188582
[No Abstract] [Full Text] [Related]
30. C9orf72 hexanucleotide repeat expansion and Guam amyotrophic lateral sclerosis-Parkinsonism-dementia complex.
Dombroski BA; Galasko DR; Mata IF; Zabetian CP; Craig UK; Garruto RM; Oyanagi K; Schellenberg GD
JAMA Neurol; 2013 Jun; 70(6):742-5. PubMed ID: 23588498
[TBL] [Abstract][Full Text] [Related]
31. Seeking environmental causes of neurodegenerative disease and envisioning primary prevention.
Spencer PS; Palmer VS; Kisby GE
Neurotoxicology; 2016 Sep; 56():269-283. PubMed ID: 27050202
[TBL] [Abstract][Full Text] [Related]
32. Genotoxic Damage During Brain Development Presages Prototypical Neurodegenerative Disease.
Kisby GE; Spencer PS
Front Neurosci; 2021; 15():752153. PubMed ID: 34924930
[TBL] [Abstract][Full Text] [Related]
33. Is neurodegenerative disease a long-latency response to early-life genotoxin exposure?
Kisby GE; Spencer PS
Int J Environ Res Public Health; 2011 Oct; 8(10):3889-921. PubMed ID: 22073019
[TBL] [Abstract][Full Text] [Related]
34. Neuropathology of parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam: an update.
Oyanagi K; Wada M
J Neurol; 1999 Sep; 246 Suppl 2():II19-27. PubMed ID: 10525999
[TBL] [Abstract][Full Text] [Related]
35. [The Current State of Amyotrophic Lateral Sclerosis/Parkinsonism-Dementia Complex in the Kii Peninsula, Japan, 2019].
Kokubo Y
Brain Nerve; 2019 Nov; 71(11):1236-1244. PubMed ID: 31722309
[TBL] [Abstract][Full Text] [Related]
36. Alteration in the expression of MGMT and RUNX3 due to non-CpG promoter methylation and their correlation with different risk factors in esophageal cancer patients.
Saikia S; Rehman AU; Barooah P; Sarmah P; Bhattacharyya M; Deka M; Deka M; Goswami B; Husain SA; Medhi S
Tumour Biol; 2017 May; 39(5):1010428317701630. PubMed ID: 28468586
[TBL] [Abstract][Full Text] [Related]
37. Enduring involvement of tau, beta-amyloid, alpha-synuclein, ubiquitin and TDP-43 pathology in the amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam (ALS/PDC).
Miklossy J; Steele JC; Yu S; McCall S; Sandberg G; McGeer EG; McGeer PL
Acta Neuropathol; 2008 Dec; 116(6):625-37. PubMed ID: 18843496
[TBL] [Abstract][Full Text] [Related]
38. A critical review of the postulated role of the non-essential amino acid, β-N-methylamino-L-alanine, in neurodegenerative disease in humans.
Chernoff N; Hill DJ; Diggs DL; Faison BD; Francis BM; Lang JR; Larue MM; Le TT; Loftin KA; Lugo JN; Schmid JE; Winnik WM
J Toxicol Environ Health B Crit Rev; 2017; 20(4):1-47. PubMed ID: 28598725
[TBL] [Abstract][Full Text] [Related]
39. [Muro disease: amyotrophic lateral sclerosis/parkinsonism-dementia complex in Kii peninsula of Japan].
Kuzuhara S
Brain Nerve; 2011 Feb; 63(2):119-29. PubMed ID: 21301036
[TBL] [Abstract][Full Text] [Related]
40. A link between ALS and short residence on Guam.
Majoor-Krakauer D; Mulder PG; Rowland LP; Ottman R
Neurology; 2005 May; 64(10):1819-20. PubMed ID: 15911829
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
